FSFariba Shirvani

Fariba Shirvani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fariba Shirvani has a total of 246 co-authors. Here are the top co-authors by number of shared publications:

  • Abdollah Karimi

    Pediatric Infections Research Center, Research Institute for Children's Health Shahid Beheshti University of Medical Sciences Tehran Iran

    13 shared publications
  • Kimia Seifi

    Young Researchers and Elite Club, Roudehen Branch, Islamic Azad University, Roudehen, Iran

    10 shared publications
  • Farideh Shiva

    Pediatric Infectious Diseases Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

    7 shared publications
  • Shahnaz Armin

    Pediatric Infections Research Center, Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    7 shared publications
  • Reza Arjmand

    Department of Pediatrics, School of Medicine, Imam Ali Hospital, Alborz University of Medical Sciences, Karaj, Iran

    6 shared publications
  • Abdollah Karimi

    Pediatric Infections Research Center, Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    5 shared publications

Latest Publications

  • Open Access

    Prevalence and Microbial Associations in Pediatric Chronic Granulomatous Disease: A Retrospective Case Series at Mofid and Masih Daneshvari Hospitals (2014 - 2019)

    by Bahar Shafaei, Narges Bazgir, Zahra Chavoshzadeh, Seyed Alireza Mahdaviani, Mehrnaz Mesdaghi, Samin Sharafian, Shahrzad Fallah, Fariba Shirvani

    Background: Chronic granulomatous disease (CGD) is an immune system disorder caused by NADPH oxidase dysfunction. This dysfunction reduces the ability of neutrophils and monocytes to combat infections, leading to recurrent infections with microorganisms such as Staphylococcus, Salmonella, and BCG. CGD is commonly diagnosed in children younger than 5 years and can cause a range of infectious and noninfectious complications. Objectives: This study aimed to describe the clinical and microbial profiles of infections in pediatric patients with CGD at two Iranian referral hospitals over a 5-year period. Methods: This retrospective consecutive case series included patients with CGD admitted to two hospitals between 2014 and 2019. All patients with confirmed CGD (nitroblue tetrazolium [NBT] < 5% or dihydrorhodamine [DHR] stimulation index < 10) were eligible. Six patients were excluded because of incomplete data or declined retrospective consent. Culture, polymerase chain reaction (PCR), and BacTec were used. Causative pathogens were defined by sterile-site isolation or clinical assessment. Fisher's exact test was used, and P < 0.05 was considered statistically significant. Results: The study included 30 patients with CGD who presented to the two hospitals between April 2014 and April 2019. Most patients were male. The mean age was 107.96 ± 59.08 months, and the median age at diagnosis was 60 months (interquartile range [IQR], 24 - 108). The mean number of hospital admissions was 1.89 (IQR, 1 - 2), and the median length of hospital stay was 25 days (IQR, 14 - 42). The most frequent clinical manifestations were pneumonia and lymphadenopathy. Streptococcus (33.3%) and Candida (30%) were the most common pathogens. No significant association was observed between the infecting microorganisms and growth status, number of admissions, immunoglobulin levels, or lesion type (Fisher's exact P > 0.05). Conclusions: Streptococcus and Candida predominated among Iranian pediatric patients with CGD, differing from global patterns. These findings support consideration of local microbial patterns when evaluating prophylactic strategies.

  • Investigating BCG Vaccine-Related Adverse Events Following BCG Vaccination in Children Referred to Healthcare Centers in Tehran and Alborz, Iran

    by Roxana Mansour Ghanaiee, Fariba Shirvani, Abdollah Karimi, Ahmad Reza Shamshiri, Foroughalsadat Pourheidari, Fariba Rasanezhad, Yasaman Aminpour, Zhilla Mohammadi, Seyedeh Mahsan Hoseini-Alfatemi

    Introduction: Bacillus Calmette-Guérin (BCG) vaccination is routinely administered at birth to prevent severe tuberculosis. Although BCG is generally safe, adverse events may occur. Therefore, this study aimed to describe reported adverse events following BCG vaccination among children referred to healthcare centers in Tehran and Alborz Provinces during one year of follow-up. Methods: This registry-based prospective descriptive cohort study included 976 children enrolled between September 2022 and February 2024. Participants attending healthcare centers in Tehran and Alborz were followed for one year, with assessments every four months. To this end, parent-reported and clinically documented adverse events were recorded using Rabbit. Finally, SPSS 23 was used for data analysis. Results: Among 976 participants, 492 (50.4%) were boys and 484 (49.6%) were girls. Diarrhea (4.20%, n = 41), skin rash (2.15%, n = 21), and fever (1.74%, n = 17) were the most frequently reported adverse events. However, decreased milk intake (1.02%, n = 10) and lymphadenopathy (0.61%, n = 6) were less common. All reported events were transient and resolved without hospitalization. Ultimately, no cases of disseminated BCG infection, osteitis, or vaccine-related mortality were observed during the follow-up. Conclusion: Reported adverse events during the follow-up were uncommon, mild, and self-limited. Given that this descriptive study lacked diagnostic confirmation and a comparison group, no causal relationship could be established between the reported events and BCG vaccination, requiring larger studies to evaluate rare BCG-related complications.

  • Open Access

    Investigation of Clinical Manifestations and Laboratory Findings of COVID-19 During National Peaks of Alpha, Beta, Delta, and Omicron in the Pediatric Emergency Department of Mofid Children's Hospital, Tehran, Iran

    by Niloofar Esfahanian, Fariba Shirvani, Narges Bazgir, Abdollah Karimi, Sedigheh Rafiei Tabatabaei, Shahnaz Armin, Seyed Alireza Fahimzad, Roxana Mansour Ghanaiee, Yasaman Esfahanian

    Background: The global spread of the coronavirus since 2019 has caused significant concern. Objectives: In this study, we aimed to investigate the clinical manifestations and laboratory findings of children infected with the alpha, beta, delta, and omicron strains. Methods: We included all patients who were referred to Mofid Children's Hospital during the peak of the alpha strain in November 2020, the beta strain in April 2021, the delta strain in August 2021, and the omicron strain in February 2022, corresponding to the national peaks of four SARS-CoV-2 variants of concern (VOC). All patients had a positive nasopharyngeal PCR test and were admitted to the emergency ward. We analyzed the collected data using SPSS software. Results: A total of 649 patients were included in this survey, of whom 58.1% were male. The most and least frequent clinical manifestations were fever and skin presentation, respectively. The mean white blood cell count (WBC) was 8423.9 ± 5427.3. The mean values for C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were 30.14 ± 20.07 and 38 ± 22.6, respectively. There was no significant association between coronavirus type, age, and gender. Gastroenteritis, urinary tract infection, and croup showed a statistically significant positive correlation with delta, beta, and omicron (P-values of < 0.003, 0.000, and 0.000, respectively). Cough was more frequent in patients infected with alpha and beta subtypes, while lymphocyte counts were elevated in patients suffering from delta, omicron, and alpha. C-reactive protein and ESR levels were significantly increased in patients with delta infection, and in patients with omicron infection, CRP levels were significantly elevated. Conclusions: Our study revealed that the different strains of COVID-19, corresponding to the World Health Organization (WHO) peak of VOCs, can cause variable clinical symptoms in children. These findings could be helpful in the diagnosis of COVID-19.


  • Open Access

    Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics

    by Shahnaz Armin, Mohammadreza Mirkarimi, Zahra Pourmoghaddas, Marjan Tariverdi, Azadeh Jafrasteh, Noushin Marhamati, Armin Shirvani, Abdollah Karimi, Sedigheh Rafiei Tabatabaei, Roxana Mansour Ghanaei, et al.

    Background. Despite the worldwide spread of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), information about the epidemiological and clinical patterns of this infection is still largely unknown in children. In addition, the prevalence of this disease is still very high in some parts of the world, including Iran. Thus, this study aims to evaluate the epidemiological features, laboratory and imaging findings, and the type of treatments in children with novel coronavirus 2019 (COVID-19). Method. This study is conducted from March 2020March 2021 by using the medical records of hospitalized confirmed COVID-19 children younger than 18 years in five cities of Iran: Tehran, Ahwaz, Isfahan, Bandar-Abbas, and Khorramabad. In addition to demographic and epidemiological data, we also studied clinical signs and treatments. Results. In total 278 confirmed COVID-19 children, the average age was 5.3 years, and 59.4were boys. A total of 37.8 had an underlying disease, in which the most common was a malignancy. The most common symptoms were fever and cough. In this group of pediatrics, some abnormal laboratory findings have been seen. GGO (Ground-Glass Opacity) had been diagnosed in 58.6 of children. 3.6 needed oxygen therapy with ventilators, and 83.09 had received antibiotic treatments with the majority of ceftriaxone. Also, 10 had got steroids. In this study, the mortality rate was 4.3. Conclusion. In this study, most of the children who died had an underlying disease, so timely care and action is important in them. Most children admitted to our study received antibiotics and were prescribed antivirals and steroids for a smaller number. Also, a small number of children received oxygen therapy, most of whom were in the age group of 1 to 5 years.


  • Open Access

    Comparison of High-resolution Melting Curve Analysis with Specific Target Gene Sequencing to Identify the Most Common Species of Aspergillus and Fusarium

    by Fariba Shirvani, Zeynab Yassin, Mahzad Erami, Ensieh Lotfali, Reza Ghasemi, Azam Fattahi

    Background: Currently, it appears that new molecular-based methods could substitute microscopic and culture assessment for the first-line detection of microorganisms isolated from clinical specimens. However, it will remain the "continual strategy" until this technology is attuned to identifying all fungi that can be isolated from biological specimens. Objectives: The present study aimed to validate a high-resolution melting (HRM) technique to identify clinical filamentous fungi. Moreover, it was attempted to compare the results with those of the target gene’s polymerase chain reaction (PCR) sequencing. Methods: A total of 54 specimens of bronchoalveolar lavage (BAL), nail, ear discharge, blood culture, and cornea were collected from patients suspected of fungal infection. All Fusarium spp. and Aspergillus spp. were recognized based on Tef-α and beta-tubulin region sequencing, as well as PCR-HRM analysis. Results: The Tef-α sequence analysis revealed the most frequent spp. to be Fusarium solani followed by F. oxysporum (n = 3), F. caucasicum (n = 3), F. coeruleum (n = 3), F. falciforme (n = 1), F. proliferatum (n = 1), F. brevicatenulatum (n = 1), F. globosom (n = 1), and F. verticillioides (n = 1). Based on the beta-tubulin sequences, Aspergillus flavus (n = 10), A. fumigatus (n = 7), A. niger (n = 2), A. terreus (n = 1), and A. orezea (n = 1) were identified in this study. Furthermore, the dataset analysis of PCR-HRM revealed that 33 isolates belonging to Fusarium spp. were F. solani (n = 24), F. oxysporum (n = 3), F. proliferatum (n = 3), F. falciforme (n = 1), F. verticillioides (n = 1), and F. brevicatenulatum (n = 1). Moreover, isolates (n = 21) belonging to Aspergillus spp. included A. flavus (n = 11), A. fumigatus (n = 7), A. niger (n = 2), and A. terreus (n = 1). Conclusions: The sequencing method has a time-consuming and costly nature, and there exists conformity between the sequence results of the Tef-α/beta-tubulin regions and PCR-HRM. The PCR-HRM method is a reliable approach in the clinical laboratory to identify Aspergillus and Fusarium spp. However, some closely related spp. show no curve algorithm differences in PCR-HRM.


  • Open Access

    Frequency and Antimicrobial Susceptibility of Bacterial Agents Causing Peritoneal Dialysis-Related Peritonitis: A Two-Center Experience

    by Fariba Shirvani, Nakysa Hooman, Abdollah Karimi, Shahnaz Armin, Alireza Fahimzad, Roxana Mansour Ghanaei, Sedigheh RafieeTabatabaei, Fatemeh Fallah

    Background: Peritonitis remains a significant complication of peritoneal dialysis (PD) in children. Objectives: The current study aimed to evaluate the causative agents of PD-related peritonitis in pediatric patients treated by continuous ambulatory peritoneal dialysis (CAPD) in order to provide evidence for improving the empirical treatment of PD-related peritonitis and avoid antimicrobial resistance. Methods: The medical records of children diagnosed with PD-related peritonitis hospitalized at Mofid and Ali-Asghar Children’s Hospitals from January 2018 to December 2019 were retrospectively reviewed. Cases of relapsing peritonitis and fungal peritonitis were excluded. Data on demographics, clinical manifestations, para-clinical evaluations, peritoneal fluid culture and antibiogram, and antibiotic regimen were analyzed. Results: A total of 23 CAPD children aged 1 - 17 years were hospitalized with a confirmed diagnosis of PD-related peritonitis, accounting for a total of 27 peritonitis cases. The most frequent manifestation of peritonitis was cloudy dialysate (85.2%), followed by abdominal pain (59.3%). Gram-negative organisms were isolated in 48.1% of cases, and 4 cases had negative cultures. The frequency of antibiotic prescription within 14 days of admission was significantly higher in culture-negative cases (P = 0.002), and abdominal pain was more prevalent in Gram-negative peritonitis (P = 0.004). All Gram-negative organisms were sensitive to ceftazidime and imipenem; while 61.6% of them were sensitive to gentamycin. All Gram-positive organisms were sensitive to cefazolin, and vancomycin was effective against all Staphylococcus strains. Oxacillin resistance was reported in 50% of Staphylococcus strains. Conclusions: PD-related peritonitis should be suspected even in cases with clear dialysis effluent who present with other manifestations of peritonitis such as fever or abdominal pain. Moreover, intraperitoneal administration of a first-generation cephalosporin (cefazolin) combined with ceftazidime was an appropriate therapeutic option for empiric therapy.

  • Open Access

    Utility of Available Methods for Diagnosing SARS-CoV-2 in Clinical Samples

    by Armin Shirvani, Leila Azimi, Roxana Mansour Ghanaie, Masoud Alebouyeh, Fatemeh Fallah, Sedigheh Rafiei Tabatabaei, Maryam Rajabnejad, Shahnaz Armin, Seyed Alireza Fahimzad, Fariba Shirvani, et al.

    : The laboratory diagnosis of SARS-CoV-2 should be done to confirm coronavirus disease 2019 (COVID-19) in suspected patients. Although several diagnostic methods have been developed in this regard, their accuracy for clinical application is not very clear yet. To compare the diagnostic value of laboratory tests for the detection of COVID-19 infection, this study provides an upcoming review of the newly developed detection methods. Sensitivity, specificity, detection limit, and turn-around-time of these methods are compared and challenges for their application in clinical settings are reviewed. PubMed and Google Scholar web sites were used for the systematic search until April 9, 2020 to identify the published studies based on the following keywords: “Detection”, “Coronavirus 2019”, “SARS-CoV-2”, and “Sensitivity”. Out of 526 results, a total of 54 articles, including 46 studies on detection methods, were considered eligible for the review. The results showed that most of the proposed tests focused on molecular methods, while immunological and point-of-care tests were investigated in 13 studies. There were also a few commercial automated methods for the qualitative detection of SARS-CoV-2 in clinical samples, most of which are not examined in the current review, as no data about their sensitivity and specificity were presented. Although the assessment of publication biases showed that 64% sensitivity and nearly 100% specificity for RT-PCR are close to reality, most of the related reports for serological methods are not valid and further studies are needed to confirm their utility in clinical settings. Moreover, the RT-PCR test alone cannot act as a gold standard because of bias in measurements. Therefore, antibody tests and other proposed methods could be used as supplementary diagnostic tests to improve RT-PCR accuracy. Although clinical findings are invaluable, in many cases, they can provide more valuable supportive data than serological tests.


  • Open Access

    Reinfection or Relapse in SARS-CoV-2-Infected Patients; Does it Occur?

    by Abdollah Karimi, Fariba Shirvani, Kimia Seifi

    Keywords Relapse SARS-COV-2 Reinfection


  • Open Access

    Rapid Detection of Cytomegalovirus and Listeria monocytogenes Infection in Symptomatic Newborns by Fluorescence End-Point Detection PCR (FEP PCR)

    by Nader Shahrokhi, Talayeh Seid Shakeri, Fariba Shirvani, Kimia Seifi

    Background: Congenital CMV infection is the most prevalent congenital infection in the world, and perinatal Listeria infection is an important cause of neonatal sepsis. The identification of these two infections is hard. The PCR technique is a sensitive method, which is not simply available in Iran. Objectives: This study investigated the prevalence of CMV and Listeria in 100 urine samples from under 21-day-old neonates with positive risk factors by PCR electrophoresis and fluorescent end-point detection (FEP) PCR in Tehran referral hospitals. Methods: We used 100 urine samples from neonates admitted to 11 medical centers in Tehran with positive selected clinical symptoms compatible with these infections. Electrophoresis and FEP PCR for CMV and Listeria were performed on all urine samples. For the data analysis, SPSS version 21 software was used, and p values of less than 0.05 were considered significant. Results: We collected 100 urine samples from 100 under 21-day-old neonates, referring to Tehran hospitals. Seven cases were positive for Listeria, and 58 cases were positive for CMV by electrophoresis and FEP PCR. Respiratory distress was the most common clinical finding in both groups. The Mc-Nemar test revealed a statistical agreement between calcification and CMV and meningitis and Listeria (P = 0.18 and 0.07, respectively). There was a positive relationship between the neonates’ age and CMV-positive condition (P = 0.001). This result was not significant among Listeria-positive cases. Conclusions: Screening for CMV and Listeria infections in neonates with clinical features compatible with these intrauterine infections may give important information for their treatment and follow-up.